LeMaitre Vascular EBITDA 2010-2024 | LMAT
LeMaitre Vascular ebitda from 2010 to 2024. Ebitda can be defined as earnings before interest, taxes, depreciation and amortization.
| LeMaitre Vascular Annual EBITDA (Millions of US $) |
|
|---|---|
| 2024 | $62 |
| 2023 | $46 |
| 2022 | $36 |
| 2021 | $47 |
| 2020 | $37 |
| 2019 | $27 |
| 2018 | $33 |
| 2017 | $25 |
| 2016 | $20 |
| 2015 | $15 |
| 2014 | $10 |
| 2013 | $7 |
| 2012 | $6 |
| 2011 | $6 |
| 2010 | $5 |
| 2009 | $3 |
| LeMaitre Vascular Quarterly EBITDA (Millions of US $) |
|
|---|---|
| 2024-12-31 | $15 |
| 2024-09-30 | $16 |
| 2024-06-30 | $17 |
| 2024-03-31 | $14 |
| 2023-12-31 | $13 |
| 2023-09-30 | $12 |
| 2023-06-30 | $12 |
| 2023-03-31 | $10 |
| 2022-12-31 | $9 |
| 2022-09-30 | $8 |
| 2022-06-30 | $8 |
| 2022-03-31 | $10 |
| 2021-12-31 | $11 |
| 2021-09-30 | $12 |
| 2021-06-30 | $14 |
| 2021-03-31 | $11 |
| 2020-12-31 | $12 |
| 2020-09-30 | $13 |
| 2020-06-30 | $7 |
| 2020-03-31 | $6 |
| 2019-12-31 | $6 |
| 2019-09-30 | $7 |
| 2019-06-30 | $7 |
| 2019-03-31 | $6 |
| 2018-12-31 | $8 |
| 2018-09-30 | $6 |
| 2018-06-30 | $13 |
| 2018-03-31 | $6 |
| 2017-12-31 | $7 |
| 2017-09-30 | $6 |
| 2017-06-30 | $7 |
| 2017-03-31 | $5 |
| 2016-12-31 | $5 |
| 2016-09-30 | $6 |
| 2016-06-30 | $5 |
| 2016-03-31 | $4 |
| 2015-12-31 | $4 |
| 2015-09-30 | $4 |
| 2015-06-30 | $4 |
| 2015-03-31 | $3 |
| 2014-12-31 | $4 |
| 2014-09-30 | $3 |
| 2014-06-30 | $3 |
| 2014-03-31 | $1 |
| 2013-12-31 | $2 |
| 2013-09-30 | $1 |
| 2013-06-30 | $2 |
| 2013-03-31 | $2 |
| 2012-12-31 | $2 |
| 2012-09-30 | $2 |
| 2012-06-30 | $2 |
| 2012-03-31 | $1 |
| 2011-12-31 | $1 |
| 2011-09-30 | $3 |
| 2011-06-30 | $1 |
| 2011-03-31 | $0 |
| 2010-12-31 | $-1 |
| 2010-09-30 | $2 |
| 2010-06-30 | $2 |
| 2010-03-31 | $2 |
| 2009-12-31 | $2 |
| 2009-09-30 | $2 |
| 2009-06-30 | $1 |
| 2009-03-31 | $-1 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | MED PRODUCTS | $2.039B | $0.220B |
| LeMaitre Vascular, Inc. is a provider of devices, implants and services for the treatment of peripheral vascular disease, a condition that affects the people worldwide. LeMaitre develops, manufactures, and markets disposable and implantable vascular devices to address the needs of vascular surgeons and interventionalists. LeMaitre's diversified product portfolio consists of twelve well-known brand name products used in arteries and veins outside of the heart and are supported by a growing, specialized and highly trained organization of vascular sales professionals. LeMaitre Vascular offers a wide range of innovative products to vascular surgeons and interventionalists for improving procedure efficacy and minimizing patient recovery time. | |||